ArticleFrontiers in immunology2026
Huayu Wan enhances immune checkpoint inhibitor efficacy in triple-negative breast cancer by normalizing tumor vasculature and remodeling the tumor immune microenvironment.
Wenjing Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.